Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0M8AR
|
|||
| Former ID |
DNC013510
|
|||
| Drug Name |
1-(5-phenyloxazol-2-yl)octadec-9-en-1-one
|
|||
| Synonyms |
CHEMBL426410; 2-Oleoyl-5-phenyloxazole; 1-(5-phenyloxazol-2-yl)octadec-9-en-1-one; SCHEMBL3205790; BDBM50161521; AKOS030561892; 1-(5-Phenyl-oxazol-2-yl)-nonadec-10-en-2-one; (Z)-1-(5-phenyloxazol-2-yl)octadec-9-en-1-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H39NO2
|
|||
| Canonical SMILES |
CCCCCCCCC=CCCCCCCCC(=O)C1=NC=C(O1)C2=CC=CC=C2
|
|||
| InChI |
1S/C27H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-22-25(29)27-28-23-26(30-27)24-20-17-16-18-21-24/h9-10,16-18,20-21,23H,2-8,11-15,19,22H2,1H3/b10-9-
|
|||
| InChIKey |
JBJNKCWDUQMEEA-KTKRTIGZSA-N
|
|||
| CAS Number |
CAS 681135-40-0
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Optimization of the central heterocycle of alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase. J Med Chem. 2008 Aug 14;51(15):4392-403. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.